| Document and Entity Information | Nov. 09, 2022 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001604950 |
| Document Type | 8-K |
| Document Period End Date | Nov. 09, 2022 |
| Entity Registrant Name | scPharmaceuticals Inc. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-38293 |
| Entity Tax Identification Number | 46-5184075 |
| Entity Address, Address Line One | 2400 District Avenue |
| Entity Address, Address Line Two | Suite 310 |
| Entity Address, City or Town | Burlington |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 01803 |
| City Area Code | (617) |
| Local Phone Number | 517-0730 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common stock, par value $0.0001 per share |
| Trading Symbol | SCPH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | true |
